Related Experiment Video

Updated: May 13, 2026

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

PELO negatively regulates HER receptor signalling and metastasis

K Pedersen1, F Canals1, A Prat2

  • 1Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Oncogene
|February 26, 2013
PubMed

Insights

Researchers identified PELO, a new protein that binds to HER2 and epidermal growth factor receptor. PELO protein inhibits cancer cell migration and metastasis by regulating PI3K/AKT signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The Human Epidermal growth factor Receptor (HER) family comprises four receptor tyrosine kinases frequently deregulated in various cancers.
  • Activated HER receptors initiate intracellular signaling pathways by recruiting adaptor and signaling molecules to the plasma membrane.
  • While many HER-interacting proteins are known, proteomic studies reveal novel, uncharacterized factors that may bind HER receptors.

Purpose of the Study:

  • To identify novel HER2-binding proteins using a cell-based approach.
  • To characterize the function of identified HER2-binding proteins in cancer signaling pathways.
  • To investigate the role of PELO in regulating HER2-mediated signaling and its impact on tumor progression.

Main Methods:

  • Cell-based assays for identifying HER2-binding proteins.
  • Proteomic analysis to discover novel HER2 interactors.
  • Biochemical assays to study protein-receptor interactions and signaling pathway modulation.
  • In vivo functional studies to assess the role of PELO in cell migration and metastasis.

Main Results:

  • Identification of several new HER2-binding proteins, including HAX1, YWHAZ, PELO, and ACP1.
  • Demonstration that PELO binds to active HER2 and epidermal growth factor receptor.
  • Evidence that PELO attenuates phosphatidylinositol 3-kinase (PI3K)/AKT signaling by regulating p85-PI3K recruitment to activated receptors.
  • Functional characterization showing PELO negatively regulates cell migration and metastasis in vivo.

Conclusions:

  • PELO is a novel regulator of HER signaling pathways.
  • PELO's interaction with HER2 and its attenuation of PI3K/AKT signaling suggest a role in inhibiting tumor progression.
  • PELO represents a potential therapeutic target for reducing cancer invasion and metastasis.

More Related Videos

Experimental Metastasis Assay08:28

Experimental Metastasis Assay

Published on: August 24, 2010

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...